|
Mechanismα-glucosidase inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 2IIT The efficacy and safety of albumin-bound paclitaxel plus gemcitabine combined with gabapentin or pregabalin for advanced pancreatic cancer: a prospective, multicenter, open phase II single arm clinical study.
/ Not yet recruitingNot ApplicableIIT A prospective cohort study on Helicobacter pylori infection, host-pathogen characteristics and clinical outcomes in Lanzhou, Gansu province
/ Not yet recruitingPhase 2IIT Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Immune Checkpoint Inhibitors and Statins for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: A Prospective, Open-Label, Single-Arm Clinical Study
100 Clinical Results associated with Lanzhou University Second Hospital
0 Patents (Medical) associated with Lanzhou University Second Hospital
100 Deals associated with Lanzhou University Second Hospital
100 Translational Medicine associated with Lanzhou University Second Hospital